We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Microarray Gene Expression Approach May Help Predict Cancer Patient Survival

By LabMedica International staff writers
Posted on 14 Apr 2014
Print article
A new predictive genetic tool is being developed that could help cancer patients and their physicians decide whether follow-up treatments are likely to help.

A 3-year study led by Jerry Shay, professor at the Cell Biology Department of the University of Texas (UT) Southwestern Medical Center (Dallas, TX, USA), investigated effects of irradiation in a lung cancer-susceptible mouse model by looking at gene expression changes, then applying the results to examine disease outcome prediction for human patients with early stage lung or breast cancer. The researchers found that they could predict which patients had a high or low chance of survival.

Carcinogenesis is an adaptive process between nascent tumor cells and their microenvironment, including the modification of inflammatory responses from antitumorigenic to protumorigenic. Radiation exposure can stimulate inflammatory responses that inhibit or promote carcinogenesis, and can damage surrounding healthy tissue. Cancer survival statistics vary depending on the stage of the cancer and when it is diagnosed. The study, described by Delgado O. et al. in Clinical Cancer Research, March 15, 2014, examined the impact of radiation exposure on mouse lung cancer progression in vivo and assessed the clinical relevance of the results to predicting survival rates for human patients. The study offers insight into helping patients assess treatment risks.

“This finding could be relevant to the many thousands of individuals affected by these cancers and could prevent unnecessary therapy,” said Prof. Shay; “We’re trying to find better prognostic indicators of outcomes so that only patients who will benefit from additional therapy receive it.”

The research team found that some types of irradiation resulted in an increase in invasive, more malignant tumors. Gene expression changes in the mice were examined from well before development of advanced cancers. The mouse genes that correlated with poor outcomes were then matched with human genes. Upon comparing the mouse predictive signatures with more than 700 human cancer patient signatures, the overall survivability of the patients correlated with the predictive signature in the mice—the classifier that predicted invasive cancer in mice also predicted poor outcomes in humans. Immunohistochemical analyses suggested that tumor cells drive predictive signature.

The findings predicted overall survival in the patients with early-stage lung- or breast- adenocarcinomas, however the genes were not predictive for patients with lung squamous cell carcinoma. Other types of cancers have yet to be tested. “Personalized medicine is coming,” said Prof. Shay; “I think this is the future—patients looking at their risks of cancer recurrence and deciding what to do next. We can better tailor the treatment to fit the individual. That’s the goal.”

Related Links:

University of Texas Southwestern Medical Center


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.